tirzepatide surmount-1 nejm 2022 weight loss percent Updates in Medicine | Phase 3 SYNCHRONIZE-1: Survodutide delivered up to 13% at 76 weeks, with substantial reductions in visceral and liver fat Read now: The SURPASS-EARLY trial
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12



























